Gateway™ Vector Conversion System with One Shot™ ccdB Survival Cells
본 제품은 LMO 제품으로, 고객 분께서 LMO 신고 시스템을 통해 직접 수입 신고를 진행해주셔야 합니다. 자세히보기
Citations & References (3)
Invitrogen™
Gateway™ Vector Conversion System with One Shot™ ccdB Survival Cells
The Gateway™ Vector Conversion System is designed to convert any vector into a Gateway™ destination vector using restriction endonucleases andRead more
Have Questions?
Catalog Number
Quantity
11828029
1 kit
Catalog number 11828029
Price (KRW)
902,000
線上優惠
Ends: 31-Dec-2025
1,061,000
Save 159,000 (15%)
Each
Add to cart
Quantity:
1 kit
Price (KRW)
902,000
線上優惠
Ends: 31-Dec-2025
1,061,000
Save 159,000 (15%)
Each
Add to cart
The Gateway™ Vector Conversion System is designed to convert any vector into a Gateway™ destination vector using restriction endonucleases and ligase. A Gateway™ cassette containing attR recombination sites flanking a ccdB gene (1) and a chloramphenicol-resistance gene are blunt-end cloned into the multiple cloning site of any vector. ccdB Survival 2 competent cells allow propagation of the Gateway™ vectors containing the ccdB gene. The Gateway™ Vector Conversion System offers: • Conversion of any expression vector into a Gateway™ destination vector • Three cassettes to construct a destination vector in the correct reading frame. Each cassette has a unique restriction site to easily distinguish the cassettes and screen for the correct orientation.
For Research Use Only. Not for use in diagnostic procedures.
The Gateway™ Vector Conversion System contains Gateway™ Reading Frame Cassettes A, B, and C.1, pENTR™-gus positive control, and One Shot™ ccdB Survival Cells. Store DNA at -20°C and competent cells at -80°C.
Frequently asked questions (FAQs)
I am using your Gateway conversion kit to adapt my own vector. What is the difference between the A, B, and C reading frame cassettes?
The A, B, and C reading frame cassettes differ by 1 nucleotide each, allowing you to generate attR sites in all 3 reading frames. Each reading frame cassette contains a unique restriction site to allow you to distinguish between them (please see table on Page 3 of the Gateway Vector Conversion System with One Shot ccdB Survival 2 T1R Competent Cells manual).
How large of a PCR product can I recombine with a pDONR vector via BP cloning? Does the same apply for TOPO-adapted Entry vectors?
There is no theoretical limit to insert size for a BP reaction with a pDONR vector. Maximum size tested in-house is 12 kb. TOPO vectors are more sensitive to insert size and 3-5 kb is the upper limit for decent cloning efficiency.
How should I clean up my attB-PCR product?
After generating your attB-PCR product, we recommend purifying it to remove PCR buffer, unincorporated dNTPs, attB primers, and any attB primer-dimers. Primers and primer-dimers can recombine efficiently with the Donor vector in the BP reaction and may increase background after transformation into E. coli, whereas leftover PCR buffer may inhibit the BP reaction. Standard PCR product purification protocols using phenol/chloroform extraction followed by ammonium acetate and ethanol or isopropanol precipitation are not recommended for purification of the attB-PCR product as these protocols generally have exclusion limits of less than 100 bp and do not efficiently remove large primer-dimer products. We recommend a PEG purification protocol (see page 17 of the Gateway Technology with Clonase II manual). If you use the above protocol and your attB-PCR product is still not suitably purified, you may further gel-purify the product. We recommend using the PureLink Quick Gel Extraction kit.
I'm trying to propagate my Gateway destination vector and am not seeing any colonies. What should I do?
Check the genotype of the cell strain you are using. Our Gateway destination vectors typically contain a ccdB cassette, which, if uninterrupted, will inhibit E. coli growth. Therefore, un-cloned vectors should be propagated in a ccdB survival cell strain, such as our ccdB Survival 2 T1R competent cells.
What is the difference between LR Clonase II and LR Clonase II Plus?
LR Clonase II Plus contains an optimized formulation of recombination enzymes for use in MultiSite Gateway LR reactions. LR Clonase and LR Clonase II enzyme mixes are not recommended for MultiSite Gateway LR recombination reactions, but LR Clonase II Plus is compatible with both multi-site and single-site LR recombination reactions.
A modified Gateway cloning strategy for overexpressing tagged proteins in plants.
Authors:Dubin MJ, Bowler C, Benvenuto G,
Journal:Plant Methods
PubMed ID:18211686
'ABSTRACT: BACKGROUND: Recent developments, including the sequencing of a number of plant genomes, have greatly increased the amount of data available to scientists and has enabled high throughput investigations where many genes are investigated simultaneously. To perform these studies, recombinational cloning methods such as the Gateway system have been adapted ... More
Trpm7 regulates cell adhesion by controlling the calcium dependent protease calpain.
Authors:Su LT, Agapito MA, Li M, T N Simonson W, Huttenlocher A, Habas R, Yue L, Runnels LW,
Journal:J Biol Chem
PubMed ID:16436382
'M-calpain is a protease implicated in the control of cell adhesion through focal adhesion disassembly. The mechanism by which the enzyme is spatially and temporally controlled is not well understood, particularly because calpain''s dependence on calcium exceeds the sub-micromolar concentrations normally observed in cells. Here we show that the channel-kinase ... More
High-throughput gateway bicistronic retroviral vectors for stable expression in mammalian cells: exploring the biologic effects of STAT5 overexpression.
Authors:Royer Y, Menu C, Liu X, Constantinescu SN,
Journal:DNA Cell Biol
PubMed ID:15231069
Stable expression of cloned genes in mammalian cells has been achieved in the past by retroviral transduction using bicistronic retroviral vectors. In these vectors, the use of an Internal Ribosome Entry Site (IRES) allows simultaneous expression of a protein of interest and a fluorescence marker. However, traditional cDNA cloning in ... More